Skip to content

Prospective Clinical Research on the Therapeutic Efficacy and Mechanism of Gait Disorder Training for Parkinson's Disease Based on VR Technology

Prospective Clinical Research on the Therapeutic Efficacy and Mechanism of Gait Disorder Training for Parkinson's Disease Based on VR Technology

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500097900
Enrollment
Unknown
Registered
2025-02-27
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

Experimental group:Clinical gait training assisted by VR glasses
Control group:Conventional active exercise training

Sponsors

Ganzhou people's hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Age 40-75 years old. 2. Patients with primary Parkinson's disease who meet the latest diagnostic criteria of the International Movement Disorder Society (MDS) and the Diagnostic Criteria for Parkinson's Disease in China (2016 Edition). 3. Diagnosis of primary Parkinson's disease, within 2-8 years of the course of the disease, Hoehn-Yahr grade 2.0-4.0. 4. Have gait disorder (enrollment criteria are patients with gait disorder as determined by medical history and UPDRS assessment: score of >=1 on UPDRS-II item 13 or 14 or 15, or score >=1 on UPDRS-III item 29 or 30).

Exclusion criteria

Exclusion criteria: 1.Those with severe behavioral problems or mental disorders. 2.Those with combined cognitive impairment (MMSE<=24 points) cannot cooperate with training. 3.Parkinson plus syndrome; secondary Parkinson's syndrome; essential tremor; cerebral infarction; cerebral hemorrhage; hydrocephalus; recent myocardial infarction; deep vein thrombosis of extremities; quadriplegia; lower limb fracture. 4.Those accompanied by failure of important organs (heart, lung, liver, kidney, etc.), malignant tumors, and those with unstable conditions. 5.Those who had other diseases in the past and have remaining gait dysfunction. 6.Those who have completed conventional gait training. 7.Others who cannot cooperate with the researcher.

Design outcomes

Primary

MeasureTime frame
"Stand-walk" timing test; Observe gait kinematic parameters by three-dimensional gait analysis.;

Secondary

MeasureTime frame
Lower limb muscle strength and muscle tone;Scale assessment.;

Countries

China

Contacts

Public ContactHu Ling

ganzhou people's hospital

hulingshennei@163.com+86 13576681258

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026